Arming for a looming courtroom battle over its Vioxx arthritis drug, Merck & Co. has hired a handful of firms for its defense. The lead firm could receive as much as $50 million for its work on Vioxx litigation, according to observers. In addition to the financial considerations, the task of compiling an outside legal team may present special challenges for a company that highly values privacy and prefers to turn to its in-house lawyers.
Awash in Vioxx Suits, Merck Is Recruiting Big-Time Help
December 7, 2004
This article requires premium access
This article requires premium access to Law.com. Please sign in or subscribe to read the full text.